Director Barbara J. Cooperman of Research Solutions, Inc. filed a Form 4 on November 18, 2026, disclosing the acquisition of stock options on November 16, 2026.

Key Highlights

  • Reporting person: Barbara J. Cooperman, Director of Research Solutions, Inc. (NASDAQ:RSSS)
  • Transaction date: November 16, 2026
  • Securities acquired: Options to purchase 12,500 shares of common stock, acquired with transaction code A
  • Exercise price: $1.89 per share
  • Price paid: $0
  • Expiration date: November 15, 2036
  • Post-transaction holdings: 12,500 derivative securities beneficially owned, held directly

Cooperman Option Grant Details and Vesting Schedule

According to the filing, Barbara J. Cooperman, a director of Research Solutions, Inc. (NASDAQ:RSSS), acquired options to purchase 12,500 shares of common stock on November 16, 2026, at an exercise price of $1.89 per share. The price of the derivative security at acquisition was reported as $0. The options are set to expire on November 15, 2036, and are held directly by the reporting person.

The filing discloses a specific vesting schedule for the options. As stated in the explanation of responses, "1/3rd of the options vest on November 16, 2027 and 1/12th of the options vest on the last day of each quarter beginning December 31, 2027 until fully vested." No portion of the options is immediately exercisable at the time of the grant.

The Form 4 was signed by David Kutil as Attorney-in-Fact on November 18, 2026. The filing covers only non-derivative Table I activity, which showed no transactions, and derivative Table II activity reflecting the option grant described above. Following the reported transaction, Cooperman beneficially owns 12,500 derivative securities in Research Solutions, Inc.

What Was Disclosed

Research Solutions, Inc. director Barbara J. Cooperman disclosed the acquisition of 12,500 stock options at an exercise price of $1.89, expiring November 15, 2036, with a graduated vesting schedule beginning November 16, 2027, filed November 18, 2026.